About EpiWatch
EpiWatch is a private company based in Baltimore, Maryland. It has reported $2,250,000 raised in 11 offerings on Form D since May 2021. Its chief executive is Teresa Prego.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Aug 19, 2026 | $0of $500K target | 0 | — | Equity, Debt, Options, Series 9 convertible note with a common stock equity kickerRule 506(b) | Form D ↗ |
| Not yet | Jul 9, 2026 | $0of $300K target | 0 | — | Debt, Options, Series 10 convertible noteRule 506(b) | Form D ↗ |
| Not yet | Sep 18, 2025 | $0of $750K target | 0 | — | Debt, Options, Series 8 convertible noteRule 506(b) | Form D ↗ |
| Oct 15, 2024 | Oct 22, 2024 | $190,000target not set | 6 | $31,667 | Debt, Options, Series 7 convertible noteRule 506(b) | Form D ↗ |
| Jul 9, 2024 | Jul 11, 2024 | $250,000of $850K target | 1 | $250K | Debt, Options, Series 6 convertible noteRule 506(b) | Form D ↗ |
| Jan 12, 2024 | Jan 22, 2024 | $300,000of $750K target | 10 | $30,000 | Debt, Options, Convertible noteRule 506(b) | Form D ↗ |
| Oct 31, 2023 | Nov 2, 2023 | $55,000of $400K target | 2 | $27,500 | Debt, Options, Convertible noteRule 506(b) | Form D ↗ |
| Jun 1, 2023 | Jun 6, 2023 | $340,000of $375K target | 9 | $37,778 | Debt, Options, Convertible noteRule 506(b) | Form D ↗ |
| Sep 6, 2022 | Sep 12, 2022 | $250,000of $375K target | 10 | $25,000 | Debt, Options, Convertible noteRule 506(b) | Form D ↗ |
| Feb 28, 2022 | Mar 7, 2022 | $415,000of $800K target | 9 | $46,111 | Debt, Options, Convertible noteRule 506(b) | Form D ↗ |
| May 7, 2021 | May 11, 2021amended May 13, 2021 | $450,000of $550K target | 5 | $90,000 | Debt, Options, Convertible noteRule 506(b) | Form D/A ↗1 earlier filing |
| Total, 11 offerings | $2,250,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EpiWatch's Form D filed Aug 19, 2026.
Earlier filings also listed Richard Thomas (director, last listed Sep 2025), Daniel Hanley (director, last listed Sep 2025), Michael Singer (director, last listed Oct 2024), Nathan Crone (executive officer, director and promoter, last listed Mar 2022) and Gregory Krauss (executive officer, director and promoter, last listed Mar 2022).